Regulus Therapeutics (RGLS) Institutional Ownership $1.63 0.00 (0.00%) (As of 01:30 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Regulus Therapeutics (NASDAQ:RGLS)CurrentInstitutional OwnershipPercentage92.38%Number ofInstitutional Buyers(last 12 months)18TotalInstitutional Inflows(last 12 months)$69.81MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$13.16M Get RGLS Insider Trade Alerts Want to know when executives and insiders are buying or selling Regulus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RGLS Institutional Buying and Selling by Quarter Ad Chaikin AnalyticsBofA is watching for a market topU.S. tech stocks have soared so high for so long that they're no longer just minting new millionaires... They're minting new billionaires. The number of American billionaires has skyrocketed over last year – their wealth hitting a record $12.1 trillion – thanks to the Nasdaq's extraordinary outperformance. But now, after two years of near-vertical gains...New warnings out of Wall Street suggest that the winds are about to change. Regulus Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC84,477$132K0.0%+285.2%0.129% 11/16/2024 Geode Capital Management LLC1,280,567$2.01M0.0%-4.0%1.955% 11/15/2024 Barclays PLC84,477$132K0.0%+285.2%0.129% 11/15/2024 Jane Street Group LLC29,580$46K0.0%N/A0.045% 11/15/2024 State Street Corp1,000,998$1.57M0.0%+3.5%1.528% 11/15/2024 RA Capital Management L.P.766,834$1.20M0.0%-87.7%1.171% Get the Latest News and Ratings for RGLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Regulus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 Point72 Asset Management L.P.893,762$1.40M0.0%N/A1.365% 11/14/2024 NEA Management Company LLC6,467,802$10.15M0.6%N/A9.875% 11/13/2024 FMR LLC328,157$515K0.0%-83.8%0.501% 11/13/2024 The Manufacturers Life Insurance Company 129,700$204K0.0%N/A0.198% 11/5/2024 Victory Capital Management Inc.398,866$626K0.0%+10.4%0.609% 10/25/2024 Tyche Wealth Partners LLC106,089$167K0.0%+920.6%0.162% 10/11/2024 Creative Planning16,466$26K0.0%N/A0.025% 10/3/2024 SG Americas Securities LLC20,800$33K0.0%N/A0.032% 8/15/2024CVI Holdings LLC401,012$716K0.6%-71.5%0.613% 8/9/2024 Renaissance Technologies LLC118,100$211K0.0%+56.4%0.180% 8/5/2024 Victory Capital Management Inc.361,386$645K0.0%-1.8%0.552% 8/1/2024 Rhumbline Advisers76,472$136K0.0%N/A0.117% 7/26/2024 Bank of New York Mellon Corp197,193$352K0.0%N/A0.301% 5/29/2024 Opaleye Management Inc.170,308$490K0.1%N/A0.260% 5/17/2024 RA Capital Management L.P.6,250,000$18M0.2%N/A9.547% 5/15/2024 NEA Management Company LLC6,467,802$18.63M1.1%N/A9.879% 5/10/2024 Vanguard Group Inc.740,215$2.13M0.0%+158.4%1.131% 5/7/2024CVI Holdings LLC1,406,250$4.05M3.9%N/A2.148% 4/22/2024 Vivo Capital LLC5,000,000$14.40M1.1%N/A7.638% 2/5/2024 Victory Capital Management Inc.271,736$348K0.0%+16.5%1.344% 11/13/2023 FMR LLC2,922,600$4.03M0.0%+32.4%14.454% 11/6/2023 Victory Capital Management Inc.233,207$322K0.0%+5.3%1.197% 8/14/2023 Prelude Capital Management LLC40,660$60K0.0%N/A0.209% 9/16/2022 Federated Hermes Inc.2,904,826$6.01M0.0%-90.0%19.850% 8/16/2022 DAFNA Capital Management LLC555,555$1.15M0.3%-90.0%3.797% 8/12/2022 Ikarian Capital LLC105,341$217K0.0%-91.8%0.722% 8/1/2022 Victory Capital Management Inc.221,506$459K0.0%-90.1%1.517% 7/19/2022Commonwealth Equity Services LLC22,000$45K0.0%-83.2%0.151% 2/14/2022 DAFNA Capital Management LLC5,555,555$1.75M0.4%N/A6.382% 1/19/2022Asymmetry Capital Management L.P.2,731,044$860K0.5%+94.9%3.137% 11/15/2021 GSA Capital Partners LLP64,708$45K0.0%-68.6%0.074% 11/4/2021Asymmetry Capital Management L.P.1,401,491$968K0.6%-3.4%1.610% 10/29/2021Commonwealth Equity Services LLC111,000$76K0.0%+38.8%0.128% 9/17/2021 Virtu Financial LLC79,193$64K0.0%N/A0.091% “Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late.8/27/2021Endurant Capital Management LP2,607,674$2.12M0.6%+9.7%2.996% 8/16/2021 State Street Corp176,494$144K0.0%N/A0.203% 8/13/2021 Geode Capital Management LLC589,196$479K0.0%+54.3%0.786% 8/13/2021 Vanguard Group Inc.3,095,237$2.52M0.0%-3.9%4.131% 8/12/2021 Lido Advisors LLC57,500$47K0.0%N/A0.077% 8/11/2021Commonwealth Equity Services LLC80,000$65K0.0%+300.0%0.107% 8/10/2021Strategic Wealth Advisors Group LLC74,800$61K0.0%N/A0.100% 8/5/2021 GSA Capital Partners LLP206,265$168K0.0%N/A0.275% 7/31/2021Asymmetry Capital Management L.P.1,450,777$1.18M0.8%-26.9%1.936% 7/15/2021 Focused Wealth Management Inc200,000$163K0.0%+100.0%0.267% 5/19/2021 Squarepoint Ops LLC159,804$249K0.0%+1,477.7%0.213% 5/17/2021Endurant Capital Management LP2,376,557$3.71M1.0%N/A3.172% 5/17/2021 Ikarian Capital LLC1,245,989$1.94M0.1%N/A1.663% 5/17/2021 Atom Investors LP337,228$526K0.1%N/A0.450% 5/17/2021 Goldman Sachs Group Inc.18,049$28K0.0%-68.0%0.024% 5/12/2021 Northern Trust Corp117,654$184K0.0%+198.4%0.157% 5/12/2021 Geode Capital Management LLC381,892$595K0.0%+493.5%0.510% 5/11/2021 Acadian Asset Management LLC465,678$726K0.0%N/A0.622% 5/11/2021Asymmetry Capital Management L.P.1,985,472$3.10M1.6%N/A2.650% 5/4/2021Commonwealth Equity Services LLC20,000$31K0.0%N/A0.027% 5/4/2021 Victory Capital Management Inc.2,227,199$3.47M0.0%+345.4%2.976% 5/3/2021 Focused Wealth Management Inc100,000$156K0.0%N/A0.134% 2/10/2021 Renaissance Technologies LLC449,200$606K0.0%N/A1.147% 2/5/2021BlackRock Inc.49,788$68K0.0%-23.2%0.127% 2/2/2021 Grimes & Company Inc.54,511$74K0.0%+127.1%0.139% 2/2/2021 GYL Financial Synergies LLC51,376$69K0.0%N/A0.131% 2/1/2021 Victory Capital Management Inc.499,989$675K0.0%N/A1.277% (Data available from 1/1/2016 forward) RGLS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RGLS shares? During the previous two years, 21 institutional investors and hedge funds held shares of Regulus Therapeutics. The most heavily invested institutionals were Vivo Capital LLC ($14.40M), NEA Management Company LLC ($10.15M), Vanguard Group Inc. ($2.13M), Geode Capital Management LLC ($2.01M), State Street Corp ($1.57M), Point72 Asset Management L.P. ($1.40M), and RA Capital Management L.P. ($1.20M).Learn more on RGLS's institutional investors. What percentage of Regulus Therapeutics stock is owned by institutional investors? 92.38% of Regulus Therapeutics stock is owned by institutional investors. Learn more on RGLS's institutional investor holdings. Which institutional investors have been buying Regulus Therapeutics stock? Of the 20 institutional investors that purchased Regulus Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: NEA Management Company LLC ($12.94M), RA Capital Management L.P. ($6.25M), Vivo Capital LLC ($5M), CVI Holdings LLC ($1.41M), Point72 Asset Management L.P. ($893.76K), FMR LLC ($716K), and Vanguard Group Inc. ($453.78K). How much institutional buying is happening at Regulus Therapeutics? Institutional investors have bought a total of 28,721,177 shares in the last 24 months. This purchase volume represents approximately $70.87M in transactions. Which Regulus Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Regulus Therapeutics stock in the last 24 months: RA Capital Management L.P. ($5.48M), FMR LLC ($1.69M), CVI Holdings LLC ($1.01M), Geode Capital Management LLC ($52.94K), and Victory Capital Management Inc. ($6.76K). How much institutional selling is happening at Regulus Therapeutics? Institutional investors have sold a total of 8,242,549 shares in the last 24 months. This volume of shares sold represents approximately $13.16M in transactions. Related Companies XOMA Major Shareholders Codexis Major Shareholders Vanda Pharmaceuticals Major Shareholders Verastem Major Shareholders Lexicon Pharmaceuticals Major Shareholders Achieve Life Sciences Major Shareholders Agenus Major Shareholders Fortress Biotech Major Shareholders Curis Major Shareholders SAB Biotherapeutics Major Shareholders This page (NASDAQ:RGLS) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regulus Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regulus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
